Sultrin

   
Google
 
Web NewDrugInformation.com

Sultrin


Drug - Sultrin
The trade name of the product as shown on the labeling.

Dosage - TABLET; VAGINAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Triple Sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)
Multiple ingredients are in alphabetical order.

Strength - 184MG;143.75MG;172.5MG
The potency of the active ingredient(s), Triple Sulfa (sulfabenzamide;sulfacetamide;sulfathiazole). May repeat for multiple part products.

Applicant - ORTHO MCNEIL PHARM
The firm name holding legal responsibility for Sultrin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 005794
The FDA assigned number to Sultrin. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Sultrin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Sultrin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Sultrin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Sultrin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Ortho Mcneil Pharmaceutical Inc
The full name of the firm holding legal responsibility for the new application of Sultrin.

Sultrin